Deals

More US-China take-privates could get feisty

14 Nov 2023

A bidding war has erupted for $1.4 bln Nasdaq-listed industrial automation solutions firm Hollysys. One would-be buyer even staged a dawn raid. If a deal succeeds, minority owners of undervalued peers could push for more value, too, as Chinese companies bid farewell to the US.

Alphabet and Robinhood split at rate fork in road

13 Nov 2023

The web search giant sold its stake in the online trading company as their shares head opposite ways. Google’s parent can thrive in a steady economy while Robinhood depends more on faster growth and high-yielding accounts. Elevated borrowing costs favor cash-generating tech.

WWE McMahon’s slugfest loss is shareholder win

13 Nov 2023

The person behind the professional wrestling firm is selling shares just after it merged with Endeavor’s UFC. That could be a precursor to him bowing to Hollywood mogul Ari Emanuel. McMahon may feel it’s anticlimactic. But giving investors clarity on leadership is a victory.

Meta’s China quest thaws thin layer of dense cube

10 Nov 2023

The $828 bln social media company plans to sell virtual reality headsets in the country, 14 years after its Facebook service was banned there. Hardware is a less thorny way to grab revenue. It also puts pressure on the US government to soften its stance on some Chinese tech.

Ping An highlights China property and policy risks

9 Nov 2023

Beijing wants to broker a bailout of troubled developer Country Garden by the $100 bln insurer, Reuters reported. Ping An denies it has been asked. Yet it’s a warning that, as local governments try to defuse debt bombs, even large private companies may face pressure to help.

Private equity superstores overstock the shelves

8 Nov 2023

Blackstone and Apollo say diversification into credit, real estate and beyond makes them better investors. They have been outraised and often outperformed, however, by more focused buyout shops like CD&R. It will take consistently higher returns to justify the conglomerate model.

Telefónica $2 bln German swoop is cheap but risky

7 Nov 2023

The Spanish telco is offering to buy out its Teutonic arm’s minority investors. On the surface, it’s a good time to pounce given the unit’s recent slump. But the immediate financial benefits are sketchy, and the debt-laden parent may have to wait years for a German turnaround.

Morgan Stanley’s new CEO inherits rich pickings

2 Nov 2023

Ted Pick has the money and backing of predecessor James Gorman to make acquisitions that will help the $120 bln Wall Street firm service more of the global elite. While many potential targets look cheap, he can take his time. The most enticing prospects aren’t for sale yet.

Sanofi sickness calls for activist tonic

2 Nov 2023

The pharma group lost nearly $27 bln of market value as it announced more investment in drugs. To keep investors happy, CEO Paul Hudson can sell its consumer business, step up dealmaking and buy back shares. Its long-suffering shareholder L’Oréal has reason to back bold action.

Brookfield’s energy transition Plan C may yet work

2 Nov 2023

The investor’s improved and final $13 bln co-bid for Australia’s Origin looks set to fail after pension fund AusSuper rejected it. A new tweak means the bidders can then launch a tender offer. It would be a desperate messy affair, but Brookfield could emerge with the upper hand.

Larry Fink’s next M&A may go in surprise direction

1 Nov 2023

BlackRock’s founder built the world’s largest fund group on audacious acquisitions. He wants to do a last deal before leaving. Absorbing an alternative asset manager is tricky, while an index compiler like MSCI could offer synergies. The wild card is a data firm like Bloomberg.

Broadcom can brave China’s sword of Damocles

31 Oct 2023

The chipmaker expects to seal its strategically shaky VMware deal as Beijing’s blessing pends amid escalating geopolitical tension. In 17 months of waiting, however, its rising shares have lifted the purchase price by 16%, to $80 bln. Boss Hock Tan is better off taking the blade.

Vodafone CEO’s iffy Spain deal is better than none

31 Oct 2023

Margherita Della Valle is selling her unit in the country for 5 bln euros to a tiny investment vehicle. Part of her payment comprises shares in the highly leveraged buyer, which is yet to raise equity of its own. But even if that effort fails, the deal still works for Vodafone.

Capital Calls: Pfizer pessimism

31 Oct 2023

Concise views on global finance: A glut of vaccines has gutted Pfizer’s valuation, leaving it lower than it was before the pandemic. That’s an over-reaction, even if its Covid-19 therapies prove worthless.

Capital Calls: McDonald’s resilience

30 Oct 2023

Concise views on global finance: The Golden Arches’ global same-store sales rose 9% thanks to both selective menu-price increases and smaller meals in different markets. It demonstrates the company’s ability to keep pace with disparate economies’ stretched consumers.

Smithfield US homecoming looks like pig in a poke

30 Oct 2023

China’s biggest pork firm may relist its US unit in New York. With $7.6 bln in market cap, investors don’t seem to attach much value to its 2013 buy. Moving West is a hedge against geopolitics, but a revaluation is unlikely if the Washington-Beijing relationship remains fraught.

Hedge fund battle turns mountain into molehill

27 Oct 2023

Daniel Och is backing a $720 mln sale of Sculptor, the investment firm he founded, after buyer Rithm raised its bid again. The extra $15 mln he gets seems out of proportion to his rage against earlier terms. Maybe sweating the small stuff is what makes millionaires billionaires.

Greenhill starts Mizuho with costly culture clash

27 Oct 2023

Scott Bok runs the M&A boutique, but also chairs the board of trustees at UPenn, where a fight over antisemitism has erupted. The Japanese bank is paying him generously to help its takeover plan thrive. A campus backlash led by Apollo’s boss threatens to exact a heavy price, too.

Capital Calls: Big Oil, Intel

27 Oct 2023

Concise views on global finance: Exxon returned $8 bln of cash to investors in the quarter, while Chevron returned some $6 bln. With investment rising and M&A on the table, investors are competing with new priorities; Intel shares jumped 10% after slowing declines in revenue.

Stellantis’ China deal maths may amplify US woes

27 Oct 2023

CEO Carlos Tavares is paying up to speed up his green push. At 4.4 times sales, the $1.6 bln deal values Chinese upstart Leapmotor more richly than larger EV peers. Splurging on a rival in the People’s Republic is also a bad look as he negotiates tense pay talks with US workers.